• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠口服和静脉注射[14C]硝酸异山梨酯后的血液和组织水平。

Blood and tissue levels of [14C]isosorbide dinitrate after oral and intravenous administration to rat.

作者信息

Reed D E, Akester J M, Prather J F, Tuckosh J R, McCurdy D H, Yeh C

出版信息

J Pharmacol Exp Ther. 1977 Jul;202(1):32-7.

PMID:874817
Abstract

Rat blood and various tissues were analyzed for levels of isosorbide dinitrate (ISDN), an antianginal drug, after the administration of 14C-labeled compound. Unaltered [14C]ISDN was found in all tissues analyzed and in the circulating blood for up to 4 hours after p.o. or i.v. administration. These results clearly show that ISDN is not completely degraded in a single pass through the liver after either route of administration. ISDN concentration (nanograms of ISDN per gram wet weight of tissue) in vascular tissue were significantly greater than other tissues or the blood.

摘要

在给予14C标记的化合物后,对大鼠血液和各种组织进行了抗心绞痛药物硝酸异山梨酯(ISDN)水平的分析。口服或静脉注射后长达4小时,在所有分析的组织和循环血液中均发现未改变的[14C]ISDN。这些结果清楚地表明,无论采用哪种给药途径,ISDN在单次通过肝脏时都不会完全降解。血管组织中的ISDN浓度(每克组织湿重中ISDN的纳克数)显著高于其他组织或血液。

相似文献

1
Blood and tissue levels of [14C]isosorbide dinitrate after oral and intravenous administration to rat.大鼠口服和静脉注射[14C]硝酸异山梨酯后的血液和组织水平。
J Pharmacol Exp Ther. 1977 Jul;202(1):32-7.
2
Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.硝酸酯类耐受性:持续口服硝酸异山梨酯后静脉注射硝酸异山梨酯的血流动力学效应
Clin Ther. 1990 Jan-Feb;12(1):31-43.
3
Blood vessel uptake and metabolism of organic nitrates in the rat.大鼠体内有机硝酸盐的血管摄取与代谢
J Pharmacol Exp Ther. 1984 Feb;228(2):334-41.
4
[Clinical evaluation of isosorbide dinitrate (ISDN) spray: a study on the plasma concentrations of ISDN and on its hemodynamic effects using three administration routes].
Masui. 1990 Dec;39(12):1660-3.
5
Pharmacokinetics and pharmacodynamics of isosorbide dinitrate.硝酸异山梨酯的药代动力学与药效学
Am Heart J. 1985 Jul;110(1 Pt 2):213-6. doi: 10.1016/0002-8703(85)90489-2.
6
[Assay of plasma isosorbide dinitrate and its metabolites after oral administration of immediate and delayed-action forms].
Ann Pharm Fr. 1989;47(4):235-41.
7
Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.硝酸异山梨酯经皮喷雾剂的生物利用度和代谢
Arzneimittelforschung. 1992 Jul;42(7):931-5.
8
[Comparative antianginal, hemodynamic and pharmacokinetic effects of isosorbide-2-mononitrate and isosorbide dinitrate in the rat].[异山梨醇-2-单硝酸酯与异山梨醇二硝酸酯在大鼠体内的抗心绞痛、血流动力学及药代动力学比较效应]
Arzneimittelforschung. 1983;33(8):1117-21.
9
[Absorption of isosorbide dinitrate in guinea-pig intestine and in the colon of sheep (author's transl)].[硝酸异山梨酯在豚鼠肠道及绵羊结肠中的吸收(作者译)]
Arzneimittelforschung. 1982;32(2):106-10.
10
Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.大鼠体内硝酸异山梨酯的处置:代谢产物药代动力学及相互作用
J Pharmacol Exp Ther. 1984 Oct;231(1):124-30.

引用本文的文献

1
Differential inhibitory effects of isosorbide dinitrate and its mononitrate metabolites on platelet aggregation and thromboxane formation.异山梨酯及其单硝酸酯代谢物对血小板聚集和血栓素形成的差异抑制作用。
Pharm Res. 1985 Mar;2(2):87-90. doi: 10.1023/A:1016346913143.
2
Kinetics of isosorbide dinitrate and relationships to pharmacological effects.硝酸异山梨酯的动力学及其与药理作用的关系。
Br J Clin Pharmacol. 1981 Jun;11(6):579-89. doi: 10.1111/j.1365-2125.1981.tb01174.x.
3
Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
静脉注射和口服后异山梨醇二硝酸酯的药代动力学及代谢
Eur J Clin Pharmacol. 1985;27(6):637-44. doi: 10.1007/BF00547041.
4
Pharmacokinetics of oral glycerol-1-nitrate.口服硝酸甘油-1的药代动力学。
Eur J Clin Pharmacol. 1986;31(2):169-75. doi: 10.1007/BF00606654.
5
Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.
Eur J Clin Pharmacol. 1990;38(2):145-7. doi: 10.1007/BF00265973.